![Mark Adams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Adams
Privat kapitalinvesterare på
Two Bear Capital Operations LLC
Profil
Mark Adams is currently a Partner at Two Bear Capital Operations LLC since 2023.
Formerly, Dr. Adams was Chief Operating Officer at Adaptive Biotechnologies Corp.
from 2021 to 2023, Managing Director & Healthcare Advanced Analytics at Leerink Partners LLC from 2018 to 2020, Chief Information Officer at Celmatix, Inc. from 2016 to 2018, Principal at Booz Allen Hamilton Holding Corp.
from 2003 to 2012, Vice President at Variagenics, Inc. from 1998 to 2003, and Chief Information Officer at Good Start Genetics, Inc. Education includes an undergraduate degree from Oberlin College in 1989 and a doctorate from Baylor College of Medicine in 1994.
Aktiva positioner av Mark Adams
| Företag | Position | Start |
|---|---|---|
Two Bear Capital Operations LLC
 Two Bear Capital Operations LLC Investment ManagersFinance Two Bear Capital invests in companies located in the United States and Canada. The firm target companies operating in the fields of biotechnology, healthcare IT, machine learning & AI, bioinformatics and information security. It provides financing for seed and early-stage capital requirements with an investment size of USD 3 - 10 million. It acts as a lead and co-lead investor and also takes a seat on the board of directors. | Privat kapitalinvesterare | 2023-09-01 |
Tidigare kända positioner av Mark Adams
| Företag | Position | Slut |
|---|---|---|
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Verksamhetschef | 2023-06-01 |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | Verksamhetschef | 2023-04-01 |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Privat kapitalinvesterare | 2020-04-01 |
Celmatix, Inc.
 Celmatix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a personalized medicine company that focuses on women’s health | Teknisk/Vetenskaplig/F&U Direktör | 2018-04-01 |
| BOOZ ALLEN HAMILTON HOLDING CORPORATION | Företagsledare/Principal | 2012-01-01 |
Mark Adamss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
77
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
Booz Allen Hamilton Holding Corp.
 Booz Allen Hamilton Holding Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a holding company which offers management & technology consulting services | Commercial Services |
Celmatix, Inc.
Celmatix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a personalized medicine company that focuses on women’s health | Health Technology |
Oberlin College
 Oberlin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Variagenics, Inc.
 Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technologies related to pharmaco-genomics | Commercial Services |
Baylor College of Medicine
 Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Good Start Genetics, Inc.
 Good Start Genetics, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostics services | Health Services |
Adaptive Biotechnologies Corp.
 Adaptive Biotechnologies Corp. BiotechnologyHealth Technology Develops minimal residual disease and immune medicine | Health Technology |
Two Bear Capital Operations LLC
Two Bear Capital Operations LLC Investment ManagersFinance Two Bear Capital invests in companies located in the United States and Canada. The firm target companies operating in the fields of biotechnology, healthcare IT, machine learning & AI, bioinformatics and information security. It provides financing for seed and early-stage capital requirements with an investment size of USD 3 - 10 million. It acts as a lead and co-lead investor and also takes a seat on the board of directors. | Finance |
